Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.
van der Heijde
D
D
Division of Rheumatology, University Hospital, Maastricht, The Netherlands.
van der Linden
S
S
Bellamy
N
N
Calin
A
A
Dougados
M
M
Khan
M A
MA
D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods; D016208:Databases, Factual; D004185:Disability Evaluation; D004493:Education; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000379:methods*; D026741:Physical Therapy Modalities; D011788:Quality of Life; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy
D018501:Antirheumatic Agents